Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Germ Cell Neoplasia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00331526
What this trial is testing

Cellular Adoptive Immunotherapy in Treating Patients With Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Hoag Memorial Hospital Presbyterian 83
Very early researchLooking for participantsNCT07628634
What this trial is testing

Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors

Who this might be right for
AdenocarcinomaBasal Cell CarcinomaSquamous Cell Carcinoma+12 more
University of California, Irvine 25
Early research (Phase 1)UnknownNCT04756934
What this trial is testing

HX008 Plus LP002 for the Treatment of Patients With Advanced Melanoma

Who this might be right for
Melanoma
Taizhou HoudeAoke Biomedical Co., Ltd. 63
Early research (Phase 1)Active Not RecruitingNCT03635632
What this trial is testing

C7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL-N)

Who this might be right for
Relapsed NeuroblastomaRefractory NeuroblastomaRelapsed Osteosarcoma+4 more
Baylor College of Medicine 94
Testing effectiveness (Phase 2)Study completedNCT00038493
What this trial is testing

Temozolomide and SCH66336 for Recurrent Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
M.D. Anderson Cancer Center 23
Testing effectiveness (Phase 2)Study completedNCT00817284
What this trial is testing

Bevacizumab and Irinotecan or Bevacizumab and Temozolomide With Concomitant Radiotherapy for Primary Glioblastoma Multiforme (GBM)

Who this might be right for
Glioblastoma Multiforme
Ulrik Lassen 60
Post-approval studies (Phase 4)Study completedNCT01959711
What this trial is testing

Randomized Clinical Trial of Posterior Retroperitoneoscopic Adrenalectomy Versus Lateral Laparoscopic Adrenalectomy

Who this might be right for
Adrenal TumorPheochromocytomaConn's Syndrome+1 more
Jagiellonian University 65
Testing effectiveness (Phase 2)Looking for participantsNCT07093814
What this trial is testing

VRT106 for Injection in Patients With Recurrent/Progressive Glioblastoma

Who this might be right for
Glioblastoma
Guangzhou Virotech Pharmaceutical Co., Ltd. 42
Not applicableNot Yet RecruitingNCT07368283
What this trial is testing

Limited Target Volume Radiotherapy After Glioblastoma Surgery

Who this might be right for
Glioblastoma (GBM)
Jiangxi Provincial Cancer Hospital 79
Testing effectiveness (Phase 2)Study completedNCT02549937
What this trial is testing

A Multi-Center, Open-Label Study of Surufatinib (HMPL-012) in Patients With Advanced Solid Tumors

Who this might be right for
Tumors
Hutchmed 130
Early research (Phase 1)Looking for participantsNCT05917145
What this trial is testing

ATM-Inhibitor WSD0628 in Combination With Radiation Therapy for Treatment of Recurrent High-Grade Glioma

Who this might be right for
Glioblastoma
Mayo Clinic 94
Early research (Phase 1)Study completedNCT01435395
What this trial is testing

Trial of Temozolomide, Bevacizumab Plus Bortezomib for Recurrent Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Emory University 12
Testing effectiveness (Phase 2)Study completedNCT02273739
What this trial is testing

Study of Orally Administered Enasidenib (AG-221) in Adults With Advanced Solid Tumors, Including Glioma, or Angioimmunoblastic T-cell Lymphoma, With an IDH2 Mutation

Who this might be right for
Solid TumorGliomaAngioimmunoblastic T-cell Lymphoma+2 more
Celgene 21
Early research (Phase 1)Study completedNCT00001577
What this trial is testing

Pilot Study of a Double Isolation Perfusion Schedule Using Melphalan Alone for Intransit Melanoma or Unresectable Sarcoma of the Extremity

Who this might be right for
MelanomaSarcoma
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Study completedNCT01071837
What this trial is testing

APG101 in Glioblastoma

Who this might be right for
Glioblastoma Multiforme
Apogenix GmbH 84
Large-scale testing (Phase 3)Study completedNCT00110019
What this trial is testing

Carboplatin and Paclitaxel With or Without Sorafenib Tosylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

Who this might be right for
Mucosal MelanomaRecurrent MelanomaStage IIIA Skin Melanoma+3 more
National Cancer Institute (NCI) 823
Not applicableStudy completedNCT07428941
What this trial is testing

Evaluating an Artificial Intelligence Tool to Help Primary Care Doctors Diagnose Skin Conditions.

Who this might be right for
Skin LesionsMelanocytic NeviMelanoma (Skin Cancer)+6 more
AI Labs Group S.L 9
Testing effectiveness (Phase 2)Study completedNCT03665545
What this trial is testing

Pembrolizumab in Association With the IMA950/Poly-ICLC for Relapsing Glioblastoma

Who this might be right for
Glioblastoma MultiformeGlioblastoma, AdultGlioma of Brain+1 more
University Hospital, Geneva 18
Not applicableUnknownNCT04004377
What this trial is testing

Acoustic Neuroma: Assessing the Quality of Life by the Scale PANQOL of Patients Operated or Supervised

Who this might be right for
Acoustic Neuroma
University Hospital, Bordeaux 200
Not applicableUnknownNCT00445783
What this trial is testing

Study of Families With Melanoma

Who this might be right for
Melanoma (Skin)
Leeds Cancer Centre at St. James's University Hospital 3,700
Next Page